Caroline Baumal Apellis Pharmaceuticals, Inc. (APLS) insider trading activity

APLS Quotes by TradingView

Caroline Baumal is Chief Medical Officer of Apellis Pharmaceuticals, Inc.. Currently has a direct ownership of 93,301 shares of APLS, which is worth approximately $2.75 Million. The most recent transaction as insider was on Jan 21, 2025, when has been sold 39,594 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.3K
59.83% 3M change
59.83% 12M change
Total Value Held $2.75 Million

Caroline Baumal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2025
BUY
Grant, award, or other acquisition
-
39,594 Added 29.79%
93,301 Common Stock
Jan 17 2025
SELL
Open market or private sale
$55,515 $29.96 p/Share
1,853 Reduced 3.34%
53,707 Common Stock
Jan 06 2025
SELL
Open market or private sale
$95,208 $33.81 p/Share
2,816 Reduced 4.82%
55,560 Common Stock
Jan 16 2024
BUY
Grant, award, or other acquisition
-
25,445 Added 30.36%
58,376 Common Stock
Jan 04 2024
SELL
Open market or private sale
$165,197 $60.05 p/Share
2,751 Reduced 7.71%
32,931 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
35,549 Added 49.91%
35,682 Common Stock
CB

Caroline Baumal

Chief Medical Officer
Waltham, MA

Track Institutional and Insider Activities on APLS

Follow Apellis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLS shares.

Notify only if

Insider Trading

Get notified when an Apellis Pharmaceuticals, Inc. insider buys or sells APLS shares.

Notify only if

News

Receive news related to Apellis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APLS